← Back to Search

Natural Extract

PediaBerry for Hemangioma (Pediaberry Trial)

Phase < 1
Waitlist Available
Led By Gayle Gordillo, MD
Research Sponsored by Gayle Gordillo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Children with hemangiomas ≤ 4 months and 2 weeks of corrected gestational age
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 month treatment period
Awards & highlights

Pediaberry Trial Summary

This trial will test whether PediaBerry can treat hemangiomas in infants. 44 infants will take PediaBerry and 22 will take a placebo. All infants will be followed until they turn 18 months old.

Pediaberry Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
Infants younger than 4 months and 2 weeks, who have hemangiomas (abnormal growth of blood vessels) and were born prematurely.

Pediaberry Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 month treatment period
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 month treatment period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Decreased Hemangioma Size
Secondary outcome measures
Decreased urinary micro RNA 126 levels

Pediaberry Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Pediaberry groupExperimental Treatment1 Intervention
PediaBerry™ is a proprietary blend powdered berry extracts
Group II: PlaceboPlacebo Group1 Intervention
Placebo: powdered sugar plus McCormick Color from Nature Food Colors Berry and Sky Blue powdered food color (https://www.mccormick.com/spices-and-flavors/extracts-and-food-colors/food-colors/color-from-nature-assorted-food-color ).

Find a Location

Who is running the clinical trial?

Gayle GordilloLead Sponsor
5 Previous Clinical Trials
134 Total Patients Enrolled
1 Trials studying Hemangioma
68 Patients Enrolled for Hemangioma
National Institute of General Medical Sciences (NIGMS)NIH
266 Previous Clinical Trials
248,562 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,678 Previous Clinical Trials
6,909,784 Total Patients Enrolled
1 Trials studying Hemangioma
105 Patients Enrolled for Hemangioma

Media Library

PediaBerry (Natural Extract) Clinical Trial Eligibility Overview. Trial Name: NCT04020419 — Phase < 1
Hemangioma Research Study Groups: Placebo, Pediaberry group
Hemangioma Clinical Trial 2023: PediaBerry Highlights & Side Effects. Trial Name: NCT04020419 — Phase < 1
PediaBerry (Natural Extract) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04020419 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities for new participants to join this experiment?

"Affirmative. The information accessible on clinicaltrials.gov reveals that this trial is actively recruiting, having been first published December 1st 2020 and most recently updated September 19th 2022. This research endeavour aims to enrol 66 patients between 2 locations."

Answered by AI

How many individuals are engaged in the current clinical trial?

"That's correct. Details hosted on clinicaltrials.gov validate that this trial is currently engaging with potential participants; it was first posted in December of last year and the most recent update occurred in September 2022. 66 volunteers are actively being sought from 2 different medical centres."

Answered by AI

Do I meet the criteria to join this medical investigation?

"Applicants must have a diagnosis of angioma and be between one month to nineteen weeks old in order to participate. To meet the demands of this trial, 66 individuals are required."

Answered by AI

Does the selection criteria for this research project include those who are younger than forty?

"This medical trial is taking on participants that are between 1 month and 19 weeks of age."

Answered by AI

Who else is applying?

What state do they live in?
Michigan
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
~3 spots leftby Mar 2025